FDA criminal investigations offices
Will become operational Jan. 1 in Miami, Kansas City and San Diego, FDA Commissioner Kessler tells FDLI annual meeting. Criminal investigators to staff offices in New York City, Chicago and the Washington, D.C. area will begin training by May 1. All six offices are expected to be functioning by June 1, Kessler said, and will each be staffed by 14 "special agents" and one "special agent in charge".
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth